Cargando…

Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke

IMPORTANCE: Although increasing evidence suggests that trimethylamine N-oxide (TMAO) is associated with atherosclerosis, little is known about whether TMAO and its related metabolites (ie, choline, betaine, and carnitine) are associated with small vessel disease. OBJECTIVE: To evaluate the associati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kijpaisalratana, Naruchorn, Ament, Zsuzsanna, Bevers, Matthew B., Bhave, Varun M., Garcia Guarniz, Ana-Lucia, Couch, Catharine A., Irvin, M. Ryan, Kimberly, W. Taylor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448304/
https://www.ncbi.nlm.nih.gov/pubmed/37610752
http://dx.doi.org/10.1001/jamanetworkopen.2023.30446
_version_ 1785094704942022656
author Kijpaisalratana, Naruchorn
Ament, Zsuzsanna
Bevers, Matthew B.
Bhave, Varun M.
Garcia Guarniz, Ana-Lucia
Couch, Catharine A.
Irvin, M. Ryan
Kimberly, W. Taylor
author_facet Kijpaisalratana, Naruchorn
Ament, Zsuzsanna
Bevers, Matthew B.
Bhave, Varun M.
Garcia Guarniz, Ana-Lucia
Couch, Catharine A.
Irvin, M. Ryan
Kimberly, W. Taylor
author_sort Kijpaisalratana, Naruchorn
collection PubMed
description IMPORTANCE: Although increasing evidence suggests that trimethylamine N-oxide (TMAO) is associated with atherosclerosis, little is known about whether TMAO and its related metabolites (ie, choline, betaine, and carnitine) are associated with small vessel disease. OBJECTIVE: To evaluate the association between TMAO and its related metabolites with features of cerebral small vessel disease, including white matter hyperintensity volume (WMHV) and acute lacunar infarction. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included patients enrolled in the Specialized Programs of Translational Research in Acute Stroke biorepository. The registry included 522 patients with acute ischemic stroke who were 18 years or older who presented at the Massachusetts General Hospital or Brigham and Women’s Hospital within 9 hours after onset between January 2007 and April 2010. The analyses in this study were conducted between November 2022 and April 2023. EXPOSURES: Plasma TMAO, choline, betaine, and carnitine were measured by liquid chromatography–tandem mass spectrometry. MAIN OUTCOMES AND MEASURES: WMHV was quantified by a semiautomated approach using signal intensity threshold with subsequent manual editing. Ischemic stroke subtype was classified using the Causative Classification System. RESULTS: Among 351 patients included in this study, the mean (SD) age was 69 (15) years; 209 patients (59.5%) were male and had a median (IQR) admission National Institute of Health Stroke Scale of 6 (3-13). The magnetic resonance imaging subgroup consisted of 291 patients with a mean (SD) age of 67 (15) years. Among these, the median (IQR) WMHV was 3.2 (1.31-8.4) cm(3). TMAO was associated with WMHV after adjustment for age and sex (β, 0.15; 95% CI, 0.01-0.29; P < .001). TMAO remained significant in a multivariate analysis adjusted for age, sex, hypertension, diabetes, and smoking (β, 0.14; 95% CI, 0-0.29; P = .05). TMAO was associated with lacunar stroke but not other ischemic stroke subtypes in a model adjusted for age, sex, hypertension, diabetes, and smoking (OR, 1.67; 95% CI, 1.05-2.66; P = .03). CONCLUSIONS AND RELEVANCE: In this observational study, TMAO was associated with cerebral small vessel disease determined by WMHV and acute lacunar infarction. The association was independent of traditional vascular risk factors.
format Online
Article
Text
id pubmed-10448304
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-104483042023-08-25 Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke Kijpaisalratana, Naruchorn Ament, Zsuzsanna Bevers, Matthew B. Bhave, Varun M. Garcia Guarniz, Ana-Lucia Couch, Catharine A. Irvin, M. Ryan Kimberly, W. Taylor JAMA Netw Open Original Investigation IMPORTANCE: Although increasing evidence suggests that trimethylamine N-oxide (TMAO) is associated with atherosclerosis, little is known about whether TMAO and its related metabolites (ie, choline, betaine, and carnitine) are associated with small vessel disease. OBJECTIVE: To evaluate the association between TMAO and its related metabolites with features of cerebral small vessel disease, including white matter hyperintensity volume (WMHV) and acute lacunar infarction. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study included patients enrolled in the Specialized Programs of Translational Research in Acute Stroke biorepository. The registry included 522 patients with acute ischemic stroke who were 18 years or older who presented at the Massachusetts General Hospital or Brigham and Women’s Hospital within 9 hours after onset between January 2007 and April 2010. The analyses in this study were conducted between November 2022 and April 2023. EXPOSURES: Plasma TMAO, choline, betaine, and carnitine were measured by liquid chromatography–tandem mass spectrometry. MAIN OUTCOMES AND MEASURES: WMHV was quantified by a semiautomated approach using signal intensity threshold with subsequent manual editing. Ischemic stroke subtype was classified using the Causative Classification System. RESULTS: Among 351 patients included in this study, the mean (SD) age was 69 (15) years; 209 patients (59.5%) were male and had a median (IQR) admission National Institute of Health Stroke Scale of 6 (3-13). The magnetic resonance imaging subgroup consisted of 291 patients with a mean (SD) age of 67 (15) years. Among these, the median (IQR) WMHV was 3.2 (1.31-8.4) cm(3). TMAO was associated with WMHV after adjustment for age and sex (β, 0.15; 95% CI, 0.01-0.29; P < .001). TMAO remained significant in a multivariate analysis adjusted for age, sex, hypertension, diabetes, and smoking (β, 0.14; 95% CI, 0-0.29; P = .05). TMAO was associated with lacunar stroke but not other ischemic stroke subtypes in a model adjusted for age, sex, hypertension, diabetes, and smoking (OR, 1.67; 95% CI, 1.05-2.66; P = .03). CONCLUSIONS AND RELEVANCE: In this observational study, TMAO was associated with cerebral small vessel disease determined by WMHV and acute lacunar infarction. The association was independent of traditional vascular risk factors. American Medical Association 2023-08-23 /pmc/articles/PMC10448304/ /pubmed/37610752 http://dx.doi.org/10.1001/jamanetworkopen.2023.30446 Text en Copyright 2023 Kijpaisalratana N et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Kijpaisalratana, Naruchorn
Ament, Zsuzsanna
Bevers, Matthew B.
Bhave, Varun M.
Garcia Guarniz, Ana-Lucia
Couch, Catharine A.
Irvin, M. Ryan
Kimberly, W. Taylor
Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title_full Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title_fullStr Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title_full_unstemmed Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title_short Trimethylamine N-Oxide and White Matter Hyperintensity Volume Among Patients With Acute Ischemic Stroke
title_sort trimethylamine n-oxide and white matter hyperintensity volume among patients with acute ischemic stroke
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448304/
https://www.ncbi.nlm.nih.gov/pubmed/37610752
http://dx.doi.org/10.1001/jamanetworkopen.2023.30446
work_keys_str_mv AT kijpaisalratananaruchorn trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT amentzsuzsanna trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT beversmatthewb trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT bhavevarunm trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT garciaguarnizanalucia trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT couchcatharinea trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT irvinmryan trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke
AT kimberlywtaylor trimethylaminenoxideandwhitematterhyperintensityvolumeamongpatientswithacuteischemicstroke